Subthalamic nucleus stimulation in a parkinsonian patient with previous bilateral thalamotomy

Goto S; Yamada K; Ushio Y; Goto, S; Yamada, K; Ushio, Y
January 2004
Journal of Neurology, Neurosurgery & Psychiatry;Jan2004, Vol. 75 Issue 1, p164
Academic Journal
case study
No abstract available.


Related Articles

  • MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson’s Disease. Schlesinger, Ilana; Eran, Ayelet; Sinai, Alon; Erikh, Ilana; Nassar, Maria; Goldsher, Dorith; Zaaroor, Menashe // Parkinson's Disease (20420080);9/2/2015, Vol. 2015, p1 

    Background. Thalamotomy is effective in alleviating tremor in Parkinson’s disease (PD). Methods. Seven PD patients, mean age 59.4 ± 9.8 years (range, 46–74) with a mean disease duration of 5.4 ± 2.8 years (range, 2–10) suffering from severe refractory tremor, underwent...

  • Tiefe Hirnstimulation bei idiopathischem Parkinson-Syndrom. Hilker, R.; Benecke, R.; Deuschl, G.; Fogel, W.; Kupsch, A.; Schrader, C.; Sixel-Döring, F.; Timmermann, L.; Volkmann, J.; Lange, M. // Der Nervenarzt;Jun2009, Vol. 80 Issue 6, p646 

    Deep brain stimulation (DBS) has been shown to be effective for levodopa-responsive symptoms and tremor in Parkinson's disease (PD). The subthalamic nucleus (STN) is the preferred target for most patients suffering from late stage motor complications of the disorder. STN DBS is superior to best...

  • Anatomical Targets Associated with Abrupt versus Gradual Washout of Subthalamic Deep Brain Stimulation Effects on Bradykinesia. Cooper, Scott E.; Driesslein, Klaus G.; Noecker, Angela M.; McIntyre, Cameron C.; Machado, Andre M.; Butson, Christopher R. // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    The subthalamic nucleus (STN) is a common anatomical target for deep brain stimulation (DBS) for the treatment of Parkinson’s disease. However, the effects of stimulation may spread beyond the STN. Ongoing research aims to identify nearby anatomical structures where DBS-induced effects...

  • St. Jude secures favorable results in Libra DBS study. Ford, Omar // Medical Device Daily;1/12/2012, Vol. 16 Issue 8, p1 

    The article reports on the positive results obtained by St. Jude Medical from a study of its Deep Brain Stimulation (DBS) devices for treating Parkinson's disease. The study, being published in the journal "Lancet Neurology," examined the safety and efficacy of the Libra and LibraXP DBS constant...

  • The Treatment of Movement Disorders by Deep Brain Stimulation Yu, Hong; Neimat, Joseph S. // Neurotherapeutics;Jan2008, Vol. 5 Issue 1, p26 

    Summary: It has been understood, for some time, that modulation of deep brain nuclei within the basal ganglia and thalamus can have a therapeutic effect in patients with movement disorders. Because of its reversibility and adjustability, deep brain stimulation (DBS) has largely come to replace...

  • Medical Therapy Alone vs Addition of Deep Brain Stimulation in Advanced PD. Piboolnurak, Panida; Kaplitt, Michael G. // Neurology Alert;Jul2010, Vol. 28 Issue 11, p85 

    IN THIS RANDOMIZED, OPEN-LABEL TRIAL, THE INVESTIGATORS recruited 366 patients with Parkinson's disease (PD) who did not have an adequate benefit from medications. Patients were randomly assigned to a group treated with medication and surgery, or medical therapy alone. Of the total, 178 patients...

  • The role of exergaming in Parkinson's disease rehabilitation: a systematic review of the evidence. Barry, Gillian; Galna, Brook; Lynn Rochester, Lynn // Journal of NeuroEngineering & Rehabilitation (JNER);2014, Vol. 11 Issue 1, p1 

    Evidence for exercise based computer games (exergaming) as a rehabilitation tool for people with Parkinson's disease (PD) is only now emerging and is yet to be synthesised. To this end, we conducted a systematic review of the exergaming literature to establish what is known about the safety,...

  • Anästhesiologische Aspekte der tiefen Hirnstimulation. Seemann, M.; Zech, N.; Lange, M.; Hansen, J.; Hansen, E. // Anaesthesist;Jul2013, Vol. 62 Issue 7, p549 

    Deep brain stimulation (DBS) provides a very effective treatment for a number of neurological diseases including Parkinson's disease, movement disorders and epilepsy. In DBS microelectrodes are positioned in defined cerebral target areas and connected to a pacemaker. It is most often performed...

  • Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials. Perestelo-Pérez, L.; Rivero-Santana, A.; Pérez-Ramos, J.; Serrano-Pérez, P.; Panetta, J.; Hilarion, P. // Journal of Neurology;Nov2014, Vol. 261 Issue 11, p2051 

    Until recent years there has been no evidence from randomized controlled trials (RCTs) on the efficacy of deep brain stimulation (DBS) for Parkinson's disease (PD). This review and meta-analysis of RCTs describes the efficacy of DBS in improving motor signs, functionality and quality of life of...

  • Rapid onset of efficacy of rasagiline in early Parkinson’s disease. Zambito Marsala, Sandro; Vitaliani, Roberta; Volpe, Daniele; Capozzoli, Francesca; Baroni, Luciana; Belgrado, Enrico; Borsato, Carlo; Gioulis, Manuela; Marchini, Corrado; Antonini, Angelo // Neurological Sciences;Nov2013, Vol. 34 Issue 11, p2007 

    Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease (PD). This naturalistic single-blind study was aimed at evaluating the rapidity of onset effect of rasagiline on motor symptoms in a cohort of early...


Read the Article


Sign out of this library

Other Topics